| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8915 |
| Human Intestinal Absorption | HIA- | 0.7936 |
| Caco-2 Permeability | Caco2- | 0.7564 |
| P-glycoprotein Substrate | Non-substrate | 0.8557 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9775 |
| Non-inhibitor | 0.9910 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9524 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6905 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7965 |
| CYP450 2D6 Substrate | Non-substrate | 0.8306 |
| CYP450 3A4 Substrate | Non-substrate | 0.7406 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8809 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9096 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9223 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9089 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9246 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9652 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8909 |
| Non-inhibitor | 0.9577 |
| AMES Toxicity | Non AMES toxic | 0.8879 |
| Carcinogens | Carcinogens | 0.5494 |
| Fish Toxicity | Low FHMT | 0.7376 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7729 |
| Honey Bee Toxicity | High HBT | 0.7199 |
| Biodegradation | Ready biodegradable | 0.5939 |
| Acute Oral Toxicity | III | 0.6795 |
| Carcinogenicity (Three-class) | Non-required | 0.6409 |